DBV TECHNOLOGIES |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.196 EUR | -1.81% |
|
+0.84% | -35.32% |
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Sector
Pharmaceuticals
Calendar
2024-05-16
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.196
EUR
Average target price
4.783
EUR
Spread / Average Target
+299.94%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -35.32% | 124M | |
| +5.48% | 71.19B | |
| +12.55% | 9.3B | |
| -13.75% | 5.01B | |
| +42.38% | 4.47B | |
| +4.51% | 3.96B | |
| +21.10% | 2.44B | |
| -19.05% | 2.41B | |
| -28.72% | 2.23B | |
| +11.13% | 2.02B |
- Stock Market
- Equities
- DBV Stock
- Funds and ETFs DBV Technologies
